Cargando…

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation

Atrial fibrillation is a complex and multifactorial disease. Although prophylactic anticoagulation has great benefits in avoiding comorbidities, adverse cardiovascular events still occur and thus in recent decades, many resources have been invested in the identification of useful markers in the prev...

Descripción completa

Detalles Bibliográficos
Autores principales:	de los Reyes-García, Ascensión M., Zapata-Martínez, Laura, Águila, Sonia, Lozano, María L., Martínez, Constantino, González-Conejero, Rocío
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988920/ https://www.ncbi.nlm.nih.gov/pubmed/36895835 http://dx.doi.org/10.3389/fcvm.2023.1135127

Ejemplares similares

Inflammatory microRNAs in cardiovascular pathology: another brick in the wall
por: Zapata-Martínez, Laura, et al.
Publicado: (2023)

MicroRNAs as New Regulators of Neutrophil Extracellular Trap Formation
por: Águila, Sonia, et al.
Publicado: (2021)

Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2020)

Editorial: MicroRNAs—clinical biomarkers for atrial fibrillation
por: Moscoso, Isabel, et al.
Publicado: (2023)

Clustering of Unhealthy Lifestyle and the Risk of Adverse Events in Patients With Atrial Fibrillation
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Identification of microRNAs as diagnostic biomarkers for atrial fibrillation: a systematic review and meta-analysis
por: Rizal, Ardian, et al.
Publicado: (2023)

MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial Infarction
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2022)

Atrial fibrillation and microRNAs
por: Santulli, Gaetano, et al.
Publicado: (2014)

Editorial: The role of genetics and non-coding RNAs in atrial fibrillation
por: Novelli, Valeria, et al.
Publicado: (2022)

Serum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysis
por: Muñoz-Bravo, Carlos, et al.
Publicado: (2023)

The Therapeutic Potential of MicroRNAs in Atrial Fibrillation
por: Xu, Xiaona, et al.
Publicado: (2020)

Modified Taiwan Atrial Fibrillation Score for the Prediction of Incident Atrial Fibrillation
por: Liao, Jo-Nan, et al.
Publicado: (2022)

Meta-Analysis of Oral Anticoagulants and Adverse Outcomes in Atrial Fibrillation Patients After Intracranial Hemorrhage
por: Liu, Xin, et al.
Publicado: (2022)

Atrial Fibrillation and Cancer
por: Hajjar, Ludhmila Abrahao, et al.
Publicado: (2021)

Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the Netherlands
por: van Doorn, Sander, et al.
Publicado: (2018)

Regulation of Coagulation Factor XI Expression by MicroRNAs in the Human Liver
por: Salloum-Asfar, Salam, et al.
Publicado: (2014)

Left atrial appendage exclusion in atrial fibrillation
por: Rozen, Guy, et al.
Publicado: (2022)

Right atrial appendage firing in atrial fibrillation
por: Baptiste, Florian, et al.
Publicado: (2022)

MicroRNA-21 mediated cross-talk between cardiomyocytes and fibroblasts in patients with atrial fibrillation
por: Pradhan, Kabita, et al.
Publicado: (2023)

Circulating MicroRNAs as Potential Biomarkers of Atrial Fibrillation
por: da Silva, Ananília Medeiros Gomes, et al.
Publicado: (2017)

Editorial: Atrial fibrillation in dementia
por: Gotzmann, Michael, et al.
Publicado: (2023)

Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation
por: Huber, K, et al.
Publicado: (2013)

Stroke prevention with rivaroxaban in higher‐risk populations with atrial fibrillation
por: Diener, H.‐C., et al.
Publicado: (2015)

Exosomes and Exosomal Non-coding RNAs Are Novel Promises for the Mechanism-Based Diagnosis and Treatments of Atrial Fibrillation
por: Chen, Chaofeng, et al.
Publicado: (2021)

Postoperative atrial fibrillation in patients with left atrial myxoma
por: Sahin, Muslum, et al.
Publicado: (2015)

Newly Diagnosed Atrial Fibrillation Is an Independent Factor for Future Major Adverse Cardiovascular Events
por: Li, Chen-Yu, et al.
Publicado: (2015)

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
por: Miao, Benjamin, et al.
Publicado: (2020)

ATRIAL FIBRILLATION AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG HOSPITALIZED COVID-19 PATIENTS
por: Aten, Kristopher, et al.
Publicado: (2022)

Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisation
por: Jung, Richard G, et al.
Publicado: (2022)

Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19
por: Cutler, Michael J., et al.
Publicado: (2022)

Mortality and Major Adverse Cardiovascular Events in Hospitalized Patients With Atrial Fibrillation With COVID-19
por: Wang, Lucas, et al.
Publicado: (2023)

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2019)

Micro-RNAs Are Related to Epicardial Adipose Tissue in Participants With Atrial Fibrillation: Data From the MiRhythm Study
por: Tran, Khanh-Van, et al.
Publicado: (2019)

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
por: Rohla, Miklos, et al.
Publicado: (2019)

GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study
por: Dalgaard, Frederik, et al.
Publicado: (2019)

Impact of components of metabolic syndrome on the risk of adverse renal outcomes in patients with atrial fibrillation: a nationwide cohort study
por: Kwon, Soonil, et al.
Publicado: (2023)

Integrated Care of Atrial Fibrillation Using the ABC (Atrial fibrillation Better Care) Pathway Improves Clinical Outcomes in Chinese Population: An Analysis From the Chinese Atrial Fibrillation Registry
por: Wang, Yu-Feng, et al.
Publicado: (2021)

Atrial cardiomyopathy markers predict ischemic cerebrovascular events independent of atrial fibrillation in patients with acute myocardial infarction
por: Li, Zhitong, et al.
Publicado: (2022)

Heart Failure and Major Adverse Cardiovascular Events in Atrial Fibrillation Patients: A Retrospective Primary Care Cohort Study
por: Moltó-Balado, P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0f6mdcuq168ledv4ua4192u3bt